DLA Piper

DLA Piper 's life sciences practice follows a cross-location and cross-sector approach, thus routinely advises on large-scale transactions in the healthcare sector. Patent litigator Philipp Cepl and Kokularajah Paheenthararajah (patent and license litigation) jointly head the team; the latter is also a qualified physician and joined the partner roster at the same time as Moritz von Hesberg (M&A) in May 2023. The team focuses on transaction support, patent law and interfacing regulatory matters, including the advertising and marketing of medical devices, market access and compliance as well as research agreements. EU regulatory issues are handled thanks to the cooperation with the EU life sciences regulatory practice, which launched in February 2023. Digital healthcare matters are covered thanks to the cooperation with the data protection and IT team.